Graham Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Sell
2,710
-3,197
-54% -$250K 0.01% 941
2025
Q4
$466K Buy
5,907
+2,145
+57% +$186K 0.02% 647
2025
Q3
$345K Sell
3,762
-6,124
-62% -$499K 0.01% 791
2025
Q2
$645K Buy
9,886
+3,921
+66% +$255K 0.02% 718
2025
Q1
$399K Sell
5,965
-393
-6% -$23.5K 0.01% 895
2024
Q4
$351K Buy
+6,358
New +$365K 0.01% 866
2024
Q2
Sell
-3,334
Closed -$230K 1029
2024
Q1
$230K Sell
3,334
-1,763
-35% -$106K 0.01% 863
2023
Q4
$281K Sell
5,097
-6,869
-57% -$378K 0.01% 745
2023
Q3
$695K Buy
11,966
+7,447
+165% +$430K 0.02% 463
2023
Q2
$243K Buy
+4,519
New +$200K 0.01% 759
2023
Q1
Sell
-8,744
Closed -$352K 1039
2022
Q4
$352K Buy
+8,744
New +$328K 0.01% 850

Other funds holding ANIP